Mini Review | Volume: 16, Issue: 7, July, 2026

Medicinal Plant-derived Phytochemicals as Adjunct Modulators of PI3K–AKT–mTOR Signaling in Breast Cancer: A Mini Review

Yan Wisnu Prajoko Davendra Putra Aryasatya Danendra Rakha Putra Respati Muflihatul Muniroh   

Open Access   

Published:  May 02, 2026

DOI: 10.1177/22313354261443042
Abstract

The phosphatidylinositol 3-kinase (PI3K)–Protein kinase B (AKT)–mechanistic target of rapamycin (mTOR) signaling axis represents one of the most important oncogenic pathways in breast cancer and a major driver of therapeutic resistance, particularly in hormone receptor–positive, and triple-negative subtypes. Although PI3K and mTOR inhibitors such as alpelisib and everolimus have improved clinical outcomes in selected patients, their broader application is limited by toxicity and adaptive resistance mechanisms. Increasing attention has therefore been directed toward medicinal plant-derived phytochemicals as multi-target modulators of this pathway. This review summarizes current mechanistic evidence showing how selected phytochemicals—including flavonoids, polyphenols, and isothiocyanates—interfere with PI3K–AKT–mTOR signaling at multiple nodes, suppress compensatory survival pathways, and enhance the efficacy of endocrine therapy, chemotherapy, and targeted agents. Rather than acting as standalone therapies, these compounds are increasingly viewed as adjunctive modulators or lead scaffolds for anticancer drug development. This mini review uniquely integrates emerging evidence on phytochemical modulation of the PI3K–AKT–mTOR axis with mechanisms of therapeutic resistance and rational combination strategies with targeted therapies. It also highlights recent advances in nanoformulation technologies that may improve phytochemical bioavailability and facilitate clinical translation in precision breast cancer therapy.


Keyword:     PI3K–AKT–mTOR signaling breast cancer phytochemicals drug resistance targeted therapy nanoformulation


Citation:

Prajoko YW, Aryasatya DP, Respati DRP, Muniroh and M. Medicinal Plant-derived Phytochemicals as Adjunct Modulators of PI3K–AKT–mTOR Signaling in Breast Cancer: A Mini Review. J Appl Pharm Sci. 2026;16(7):295-307. https://doi.org/10.1177/22313354261443042

Copyright: © The Author(s). This open-access article is distributed under the Creative Commons Attribution-NonCommercial 4.0 International License, which permits non-commercial use, sharing, adaptation, distribution, and reproduction in any medium or format, provided appropriate credit is given, a link to the license is included, and any changes are indicated.

HTML Full Text

Reference

Article Metrics
61 Views 56 Downloads 117 Total

Year

Month

Related Search

By author names